D-NIB Injection
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Decitabine (50mg)
Overview D-NIB Injection
Decitabine injection treats acute myeloid leukemia (AML), a type of blood cancer, and myelodysplastic syndrome (MDS). Its use may extend to other conditions as directed by a physician. Decitabine is often part of combination chemotherapy regimens, administered intravenously under medical supervision. Dosage and frequency are tailored to the patient's condition and may vary; precise adherence to the physician's instructions is crucial. Incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinuation should only occur under medical guidance. Common side effects include nausea, vomiting, diarrhea, headache, fever, and pneumonia. Decitabine can lower blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver function, and uric acid, are necessary. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, particularly those for infections, as interactions are possible. Decitabine is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is essential throughout treatment.
Uses of D-NIB Injection
Bone marrow failure disorder | Hematologic malignancy
Major Benefits of D-NIB Injection:
This medication will be administered by your physician or their qualified nursing staff. Self-medication is strictly prohibited.
Common Side effects of D-NIB Injection:
- Nausea
- Vomiting
- Headache
- Fever
- Lung infection
- Decreased white blood cell count (neutrophils)
- Nosebleeds
- Anemia (low number of red blood cells)
- Low blood platelets
- Diarrhea
- Pneumonia
How to use D-NIB Injection:
This medication will be administered by your healthcare provider. Unauthorized self-medication is strictly prohibited.
How D-NIB Injection works:
D-NIB Injection disrupts cancer cell proliferation by replacing essential DNA and RNA components, thereby inhibiting their growth and replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside D-NIB Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering D-NIB Injection during pregnancy is contraindicated due to established risks to the fetus. Nevertheless, in exceptional life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the inherent dangers. Patient consultation with their doctor is essential.
Breast feedingUNSAFE
Administering D-NIB Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering D-NIB Injection may induce adverse reactions that impair driving capabilities. Fatigue or weakness following D-NIB Injection may also negatively impact driving ability.
KidneyCAUTION
Patients with impaired kidney function should use D-NIB Injection judiciously. A modified D-NIB Injection dosage may be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding D-NIB Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take D-NIB Injection :
NA
Facts to Know About D-NIB Injection
| Label | Value |
|---|---|
| Pharmaceutical Category | Azacitidine analog |
| Potential for Dependence | None. |
| Type of Treatment | Cancer-fighting drugs |
| Mechanism of Action | Metabolic inhibitors |
3,018 People bought this recently